Ursodeoxycholic Acid Market Predicted to Exceed US$ 1,075.5 Million by 2026 – Coherent Market Insights
SEATTLE, April 12, 2021, (PHARMIWEB) — The global ursodeoxycholic acid (UCDA) market was pegged at US$ 457.3 million in 2017 and is further estimated to exhibit a CAGR of 10.1% during the forecast period (2018-2026).
Market Analysis:
Rampant development of liquid ursodeoxycholic acid has offered ample growth opportunities to the companies operating in the global ursodeoxycholic acid market in the recent past. With the introduction of liquid formulations of ursodeoxycholic acid, healthcare professionals are now able to prescribe an alternate dosing method to patients who have difficulty in swallowing tablets or capsules. Extensive R&D of ursodeoxycholic acid, along with a high prevalence of diseases like gallstone and liver cirrhosis, has majorly boosted the global ursodeoxycholic acid market development.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/2199
The solid dosage form segment spearheaded the global ursodeoxycholic acid market in 2018, owing to the development of capsule and tablet form of Ursodeoxycholic acid (UDCA) by renowned manufacturers like as Grindex and Intercept Pharmaceuticals, for the treatment of primary biliary cholangitis.
Furthermore, on the basis of the application outlook, the gall stones segment held dominant position in the ursodeoxycholic acid market in 2018, owing to increasing incidence of the condition. According to the American Gastroenterological Association’s 2017 report, gallstones affects around 15% of the U.S. population annually.
Among regions, Asia Pacific is projected to lead the global ursodeoxycholic acid market over the forecast timeline, buoyed by important factors, such as a high prevalence of diseases like gallstones and liver cirrhosis across the region. As per the data published by the OMICS International, liver cirrhosis led to around 1.2 million deaths in India in 2013. In February, 2019, EA Pharma developed a nor-ursodeoxycholic acid for the treatment of primary sclerosing cholangitis (PSC) and non-alcoholic steatohepatitis (NASH) in Japan.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2199
Competitive Scenario:
The global ursodeoxycholic acid market players include Dipharma Francis Srl, ERREGIERRE S.p.A., Grindeks, Industria Chimica Emiliana, Mitsubishi Tanabe Pharma Corporation, Zhongshan Belling Biotechnology Co., Glenmark Pharmaceutical Limited, Abil Chempharma Private Limited, Biotavia Labs Pvt. Ltd, Daewoong Bio Inc., PharmaZell GmbH, and Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
These market players are actively looking to patents for the liquid formulation of UDCA. For instance, in June 2016, Retrophin, Inc. signed a definitive agreement to purchase rights, titles, and ownership of a liquid formulation of ursodeoxycholic acid from Asklepion Pharmaceuticals, LLC.
In 2017, Retrophin announced its plans to file a new drug application (NDA) with the U.S. Food and Drug Administration for the liquid formulation of ursodeoxycholic acid, to be used in the treatment of primary biliary cholangitis (PBC).
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/ursodeoxycholic-acid-market-to-surpass-us-10755-million-by-2026-1145
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Dosage Form
- Market Snippet, By Mode of Extraction
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- PORTER’s Analysis
- Epidemiology
- Pipeline Analysis
- Market Dynamics
- Global Ursodeoxycholic Acid Market, By Dosage Form, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Solid Dosage Form
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Liquid Dosage Form
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Ursodeoxycholic Acid Market, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Biological
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Ursodeoxycholic Acid Market, By Application, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Gallstones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Liver Cirrhosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Ursodeoxycholic Acid Market, By Region, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
